# Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/standard-chemotherapy-with-or-without-bevacizumab-for-women-with-newly-diagnosed/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amit M. Oza,Adrian Cook,Jacobus Pfisterer,Andrew Embleton-Thirsk,Jonathan A. Ledermann,Éric Pujade-Lauraine,Gunnar B. Kristensen,Mark S. Carey,Philip Beale,Andrés Cervantes,Tjoung‐Won Park‐Simon,Gordon Rustin,Florence Joly,Mansoor Raza Mirza,Marie Plante,Michael Quinn,Andrés Poveda,Gordon C. Jayson,Dan Stark,Ann Marie Swart,Laura Farrelly,Richard Kaplan,Mahesh Parmar,Timothy Perren |
| Citations | 868 |
| DOI | 10.1016/s1470-2045(15)00086-8 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.thelancet.com/article/S1470204515000868/pdf |
| OpenAlex ID | https://openalex.org/W2102306754 |
| PMID | 26115797 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)
- [Mansoor Raza Mirza](https://scholariq.org/researchers/mansoor-raza-mirza/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.